Publications by authors named "Stephan Richter"

Claim this Profile
V
VirJenDB: a FAIR (meta)data and bioinformatics platform for all viruses.
Shahram Saghaei, Malte Siemers, Kilian L Ossetek, Stephan Richter, Robert A Edwards

Nucleic Acids Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors - Results from the PROSa Study.
Hanna Salm, Markus K Schuler, Leopold Hentschel, Stephan Richter, Peter Hohenberger

Oncol Res Treat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers.
Siyer Roohani, Jolina Handtke, Kamal Hummedah, Markus Albertsmeier, Dimosthenis Andreou, Stephan Richter

J Cancer Res Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study.
Tjalf Ziemssen, Ann D Bass, Bart Van Wijmeersch, Sara Eichau, Stephan Richter

Ther Adv Neurol Disord· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Follow-Up of COVID-19 Cases in District of Constance, Germany. A Prospective, Controlled Cohort Study (FSC19-KN).
Ann-Kathrin Kohler, Stephan Richter, Michael Schmid, Heidi Zimmermann, Hannes Winterer

J Clin Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers.
Siyer Roohani, Jolina Handtke, Kamal Hummedah, Markus Albertsmeier, Dimosthenis Andreou, Stephan Richter

J Cancer Res Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional study.
Paula Schade, Hai-Anh Nguyen, Julia Steinle, Kerstin Hellwig, Teodor Pelea, Stephan Richter

Ther Adv Neurol Disord· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ePROs in the routine care of a major oncology center: Results and experiences].
Martin Eichler, Leopold Hentschel, Beate Hornemann, Markus Schuler, Stephan Richter

Z Evid Fortbild Qual Gesundhwes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DeepMesh: Differentiable Iso-Surface Extraction.
Benoit Guillard, Edoardo Remelli, Artem Lukoianov, Pierre Yvernay, Stephan R Richter

IEEE Trans Pattern Anal Mach Intell· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13).
Bernd Kasper, Daniel Pink, Christian Rothermundt, Stephan Richter, Marinela Augustin

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa study.
Martin Eichler, Leopold Hentschel, Susanne Singer, Beate Hornemann, Stephan Richter

Front Endocrinol (Lausanne)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study.
Sergio Armando Zapata Bonilla, Marius Fried, Susanne Singer, Leopold Hentschel, Stephan Richter

J Cancer Res Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shock.
Uwe Zeymer, Christiane Lober, Stephan Richter, Christoph B Olivier, Kurt Huber

Eur Heart J Acute Cardiovasc Care· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome.
Rainer Hamacher, Xiaofei Liu, Markus K Schuler, Leopold Hentschel, Patrick Schöffski, Stephan Richter

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Photorealism Enhancement.
Stephan R Richter, Hassan Abu Alhaija, Vladlen Koltun

IEEE Trans Pattern Anal Mach Intell· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment.
Silvia Hofer, Leopold Hentschel, Stephan Richter, Veronika Blum, Michael Kramer

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort.
Jens Jakob, Leopold Hentschel, Stephan Richter, Inga Kreisel, Peter Hohenberger

Oncol Res Treat· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distress in soft-tissue sarcoma and gastrointestinal stromal tumours patients-Results of a German multicentre observational study (PROSa).
Martin Eichler, Leopold Hentschel, Susanne Singer, Beate Hornemann, Peter Hohenberger, Stephan Richter

Psychooncology· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression-based prediction of pazopanib efficacy in sarcoma.
Christoph E Heilig, Andreas Laßmann, Sadaf S Mughal, Andreas Mock, Sebastian Pirmann, Stephan Richter, Daniela Richter

Eur J Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN).
Elisabeth Haberland, Jonas Haberland, Stephan Richter, Michael Schmid, Julia Hromek

Int J Clin Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany.
Tjalf Ziemssen, Stephan Richter, Mathias Mäurer, Mathias Buttmann, Boris Kreusel

Front Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa).
Martin Eichler, Susanne Singer, Leopold Hentschel, Stephan Richter, Peter Hohenberger

Br J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
Sandra Heuschkel, Theresa Kretschmann, Raphael Teipel, Simone von Bonin, Stephan Richter

Cancer Chemother Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa).
Martin Eichler, Daniel Pink, Franka Menge, Jens Jakob, Leopold Hentschel, Stephan Richter

Eur J Cancer Care (Engl)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study.
Tjalf Ziemssen, Frank Hoffmann, Stephan Richter, Ulrich Engelmann, Robin White

Front Neurol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis